Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1776413 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL8387794 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL9509191 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL2188453 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL20394323 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL18327083 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL1776604 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL20253212 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL21641724 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL9233922 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 541 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8597620-B2 | Composition comprising a tocopherol phosphate and preparation process | LVMH RECHERCHE (FR) | 2013-12-03 | — | — | US | claimed |
| US-20120171134-A1 | COMPOSITION COMPRISING A TOCOPHEROL PHOSPHATE AND PREPARATION PROCESS | LVME RECHERCHE (FR) | 2012-07-05 | — | — | US | claimed |
| US-6117418-A | POLYOXYPROPYLENE GLYCOL POLYOL, PLASTICIZER, GELLING AGENT, AND SOLVENT; TRANSPARENT DEODORANTS | AVON PRODUCTS, INC. (US) | 2000-09-12 | — | — | US | claimed |
| CN-116456956-B | Solid cosmetic material | SHISEIDO CO.,LTD. (JP) | 2026-05-26 | — | — | CN | disclosed |
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2026-03-19 | — | — | US | disclosed |
| US-12564549-B2 | Cleanser composition | SHISEIDO COMPANY, LTD. (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4687818-A1 | COMPOSITION COMPRISING AN ALKYL- AND/OR ALKENYLGLYCOSIDE | KAO CORPORATION, S.A. (ES) | 2026-02-11 | — | — | EP | disclosed |
| EP-4019616-B1 | QUATERNARY ESTER AMMONIUM COMPOUND COMPOSITIONS | KAO CORP SA (ES) | 2026-01-28 | — | — | EP | disclosed |
| EP-4682106-A1 | FATTY ACID-TREATED ZINC OXIDE PARTICLES, METHOD FOR PRODUCING SAME, AND DISPERSION AND COSMETIC HAVING SAME BLENDED THEREIN | Sakai Chemical Industry Co., Ltd. (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20250319011-A1 | COMPOSITION COMPRISING AN ALKYL AND/OR ALKENYLGLYCOSIDE DERIVATIVE AND AN ESTER DERIVED FROM A HYDROXYCARBOXYLIC ACID AND A FATTY ALCOHOL | KAO CORP SA (ES) | 2025-10-16 | — | — | US | disclosed |
| EP-4628568-A1 | GEL CLEANING AGENT AND METHOD FOR PRODUCING THE SAME | Shiseido Honeycake Industries Co., Ltd. (JP) | 2025-10-08 | — | — | EP | disclosed |
| EP-0572080-A1 | Aqueous perfume oil microemulsions | QUEST INTERNATIONAL B.V. (NL) | 1993-12-01 | — | — | EP | disclosed |
| EP-0571677-A1 | Aqueous parfume oil microemulsions | UNILEVER PLC (GB) | 1993-12-01 | — | — | EP | disclosed |
| EP-0535367-A2 | Emulsified hair cosmetic composition | Kao Corporation (JP) | 1993-04-07 | — | — | EP | disclosed |
| US-5120716-A | Drug, anionic surfactant and either amphoteric nonionic or semi-polar surfactant containing nitrogen | SHISEIDO COMPANY LTD. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0487404-A1 | External dermatological composition | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1992-05-27 | — | — | EP | disclosed |
| US-5015469-A | Water swellable clays, cationic surfactants, an alkoxy modified polysiloxane in water | SHIDEIDO COMPANY LTD. (JP) | 1991-05-14 | — | — | US | disclosed |
| US-4885402-A | Process for preparing nonionic surfactants from glycerol monochlorohydrin, in an aromatic solvent medium, products obtained and compositions containing them | L'OREAL (FR) | 1989-12-05 | — | — | US | disclosed |
| EP-0331833-A1 | Water-in-oil emulsion type cosmetics | SHISEIDO COMPANY LIMITED (JP) | 1989-09-13 | — | — | EP | disclosed |
| EP-0303713-A1 | PERCUTANEOUS ABSORPTION PROMOTER AND DERMATOLOGIC PREPARATION FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 1989-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SGMS1, SGMS2, CETP | LMNA 905/4885CYP3A4 1754/4885TSHR 4589/4885 |
| US-20250319011-A1 | COMPOSITION COMPRISING AN ALKYL AND/OR ALKENYLGLYCOSIDE DERIVATIVE AND AN ESTER DERIVED FROM A HYDROXYCARBOXYLIC ACID AND A FATTY ALCOHOL | ALKBH3, CUTA, FASN | LMNA 987/4885CYP3A4 1050/4885TSHR 3896/4885 |
| US-12564549-B2 | Cleanser composition | LIPA, SGMS1, SGMS2 | LMNA 1325/4885CYP3A4 4440/4885TSHR 3400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.